Isolation and Characterization of Tissue-Type Plasminogen Activator-Binding Proteoglycans From Human Umbilical Vein Endothelial Cells

We analyzed the tissue-type plasminogen activator (TPA)-binding proteoglycans (PGs) on human umbilical vein endothelial cells (HUVECs), which were metabolically labeled with [sup 35 S]Na2 SO4. Cell extracts were then prepared and subjected to affinity chromatography on diisopropyl fluorophosphate (D...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arteriosclerosis, thrombosis, and vascular biology thrombosis, and vascular biology, 1996-05, Vol.16 (5), p.665-672
Hauptverfasser: Bohm, Thomas, Geiger, Margarethe, Binder, Bernd R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 672
container_issue 5
container_start_page 665
container_title Arteriosclerosis, thrombosis, and vascular biology
container_volume 16
creator Bohm, Thomas
Geiger, Margarethe
Binder, Bernd R
description We analyzed the tissue-type plasminogen activator (TPA)-binding proteoglycans (PGs) on human umbilical vein endothelial cells (HUVECs), which were metabolically labeled with [sup 35 S]Na2 SO4. Cell extracts were then prepared and subjected to affinity chromatography on diisopropyl fluorophosphate (DFP)-inactivated TPA-Sepharose 4B. Approximately 6% of the incorporated Sulfur radioactivity bound to DFP-treated TPA-Sepharose 4B and was eluted with 2 mol/L NaCl. In addition to NaCl, heparin, arginine, and lysine but not glycine, epsilon-amino-n-caproic acid, or aspartic acid inhibited this binding and eluted the bound Sulfur radioactivity. Urea-containing polyacrylamide gel electrophoresis of the eluted material consistently revealed two main signals of Sulfur radioactivity (one with an M sub r between 600 000 and 750 000 [PGA] and the other with an Mr between 120 000 and 180 000 [PGC]). Occasionally a less intense signal with an Mr between 340 000 and 440 000 (PGB) was seen. Heparitinase treatment markedly decreased the intensities of both Sulfur signals (PGA and PGB), and chondroitinases AC and ABC abolished the Sulfur signal of PGC, indicating that most of the HUVEC-incorporated radioactivity with an affinity for TPA could be attributed to heparan sulfate- and chondroitin sulfate-like structures. Reductive elimination, which was performed to separate the possible glycosaminoglycan moieties from the core proteins, confirmed the PG-like nature of this material and again revealed heparan sulfate and chondroitin sulfate as the major glycosaminoglycan components. We therefore conclude that HUVECs synthesize TPA-binding, heparan sulfate- and chondroitin sulfate-containing PGs. In vivo, similar PGs may play a role in TPA binding to endothelial cells and thereby possibly influence TPA activity and/or provide an intravascular storage pool of TPA. (Arterioscler Thromb Vasc Biol. 1996;16:665-672.)
doi_str_mv 10.1161/01.ATV.16.5.665
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78036752</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17465554</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4678-76fdb21425a2335dd5a07ccbb31fa878009fe55ee46029260d551cbaa7d8a31c3</originalsourceid><addsrcrecordid>eNpdkU1vEzEQhlcIVErhzAnJQojbpv727jFELa1UiR7SXq1Zrzdx8drB3qUKd_43jhL1wGE045nHr0bzVtVHgheESHKJyWK5flwQuRALKcWr6pwIymsumXxdaqzaWkhO31bvcn7CGHNK8Vl11rSSKcrPq7-3OXqYXAwIQo9WW0hgJpvcn2MzDmjtcp5tvd7vLLr3kEcX4sYGtDST-w1TTPU3F3oXNug-xcnGjd8bCBldpziim3mEgB7GznlnwKNH6wK6Cn2ctta70lhZ7_P76s0APtsPp3xRPVxfrVc39d2P77er5V1tuFRNreTQd5RwKoAyJvpeAFbGdB0jAzSqwbgdrBDWcolpSyXuhSCmA1B9A4wYdlF9PeruUvw12zzp0WVTNoBg45x1kWBSCVrAz_-BT3FOoeymablh03LFC3R5hEyKOSc76F1yI6S9Jlgf3NGY6OKOJlILXdwpPz6dZOdutP0Lf7KjzL-c5pDLtYYEwbj8gjHccCUOMvyIPUdfvMo__fxsk95a8NNWH1xmEouatG1J5VmXwA37B7reqF4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>204289474</pqid></control><display><type>article</type><title>Isolation and Characterization of Tissue-Type Plasminogen Activator-Binding Proteoglycans From Human Umbilical Vein Endothelial Cells</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>Alma/SFX Local Collection</source><creator>Bohm, Thomas ; Geiger, Margarethe ; Binder, Bernd R</creator><creatorcontrib>Bohm, Thomas ; Geiger, Margarethe ; Binder, Bernd R</creatorcontrib><description>We analyzed the tissue-type plasminogen activator (TPA)-binding proteoglycans (PGs) on human umbilical vein endothelial cells (HUVECs), which were metabolically labeled with [sup 35 S]Na2 SO4. Cell extracts were then prepared and subjected to affinity chromatography on diisopropyl fluorophosphate (DFP)-inactivated TPA-Sepharose 4B. Approximately 6% of the incorporated Sulfur radioactivity bound to DFP-treated TPA-Sepharose 4B and was eluted with 2 mol/L NaCl. In addition to NaCl, heparin, arginine, and lysine but not glycine, epsilon-amino-n-caproic acid, or aspartic acid inhibited this binding and eluted the bound Sulfur radioactivity. Urea-containing polyacrylamide gel electrophoresis of the eluted material consistently revealed two main signals of Sulfur radioactivity (one with an M sub r between 600 000 and 750 000 [PGA] and the other with an Mr between 120 000 and 180 000 [PGC]). Occasionally a less intense signal with an Mr between 340 000 and 440 000 (PGB) was seen. Heparitinase treatment markedly decreased the intensities of both Sulfur signals (PGA and PGB), and chondroitinases AC and ABC abolished the Sulfur signal of PGC, indicating that most of the HUVEC-incorporated radioactivity with an affinity for TPA could be attributed to heparan sulfate- and chondroitin sulfate-like structures. Reductive elimination, which was performed to separate the possible glycosaminoglycan moieties from the core proteins, confirmed the PG-like nature of this material and again revealed heparan sulfate and chondroitin sulfate as the major glycosaminoglycan components. We therefore conclude that HUVECs synthesize TPA-binding, heparan sulfate- and chondroitin sulfate-containing PGs. In vivo, similar PGs may play a role in TPA binding to endothelial cells and thereby possibly influence TPA activity and/or provide an intravascular storage pool of TPA. (Arterioscler Thromb Vasc Biol. 1996;16:665-672.)</description><identifier>ISSN: 1079-5642</identifier><identifier>EISSN: 1524-4636</identifier><identifier>DOI: 10.1161/01.ATV.16.5.665</identifier><identifier>PMID: 8963724</identifier><identifier>CODEN: ATVBFA</identifier><language>eng</language><publisher>Philadelphia, PA: American Heart Association, Inc</publisher><subject>Biological and medical sciences ; Blood coagulation. Blood cells ; Cells, Cultured ; Chondroitin Sulfates - isolation &amp; purification ; Chondroitin Sulfates - metabolism ; Electrophoresis, Polyacrylamide Gel ; Endothelium, Vascular - cytology ; Endothelium, Vascular - metabolism ; Fundamental and applied biological sciences. Psychology ; General aspects, investigation methods, hemostasis, fibrinolysis ; Glycosaminoglycans - isolation &amp; purification ; Glycosaminoglycans - metabolism ; Heparitin Sulfate - isolation &amp; purification ; Heparitin Sulfate - metabolism ; Humans ; Molecular and cellular biology ; Proteoglycans - isolation &amp; purification ; Proteoglycans - metabolism ; Tissue Plasminogen Activator - metabolism ; Umbilical Veins - cytology ; Umbilical Veins - metabolism</subject><ispartof>Arteriosclerosis, thrombosis, and vascular biology, 1996-05, Vol.16 (5), p.665-672</ispartof><rights>1996 American Heart Association, Inc.</rights><rights>1996 INIST-CNRS</rights><rights>Copyright American Heart Association, Inc. May 1996</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4678-76fdb21425a2335dd5a07ccbb31fa878009fe55ee46029260d551cbaa7d8a31c3</citedby><cites>FETCH-LOGICAL-c4678-76fdb21425a2335dd5a07ccbb31fa878009fe55ee46029260d551cbaa7d8a31c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3084755$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8963724$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bohm, Thomas</creatorcontrib><creatorcontrib>Geiger, Margarethe</creatorcontrib><creatorcontrib>Binder, Bernd R</creatorcontrib><title>Isolation and Characterization of Tissue-Type Plasminogen Activator-Binding Proteoglycans From Human Umbilical Vein Endothelial Cells</title><title>Arteriosclerosis, thrombosis, and vascular biology</title><addtitle>Arterioscler Thromb Vasc Biol</addtitle><description>We analyzed the tissue-type plasminogen activator (TPA)-binding proteoglycans (PGs) on human umbilical vein endothelial cells (HUVECs), which were metabolically labeled with [sup 35 S]Na2 SO4. Cell extracts were then prepared and subjected to affinity chromatography on diisopropyl fluorophosphate (DFP)-inactivated TPA-Sepharose 4B. Approximately 6% of the incorporated Sulfur radioactivity bound to DFP-treated TPA-Sepharose 4B and was eluted with 2 mol/L NaCl. In addition to NaCl, heparin, arginine, and lysine but not glycine, epsilon-amino-n-caproic acid, or aspartic acid inhibited this binding and eluted the bound Sulfur radioactivity. Urea-containing polyacrylamide gel electrophoresis of the eluted material consistently revealed two main signals of Sulfur radioactivity (one with an M sub r between 600 000 and 750 000 [PGA] and the other with an Mr between 120 000 and 180 000 [PGC]). Occasionally a less intense signal with an Mr between 340 000 and 440 000 (PGB) was seen. Heparitinase treatment markedly decreased the intensities of both Sulfur signals (PGA and PGB), and chondroitinases AC and ABC abolished the Sulfur signal of PGC, indicating that most of the HUVEC-incorporated radioactivity with an affinity for TPA could be attributed to heparan sulfate- and chondroitin sulfate-like structures. Reductive elimination, which was performed to separate the possible glycosaminoglycan moieties from the core proteins, confirmed the PG-like nature of this material and again revealed heparan sulfate and chondroitin sulfate as the major glycosaminoglycan components. We therefore conclude that HUVECs synthesize TPA-binding, heparan sulfate- and chondroitin sulfate-containing PGs. In vivo, similar PGs may play a role in TPA binding to endothelial cells and thereby possibly influence TPA activity and/or provide an intravascular storage pool of TPA. (Arterioscler Thromb Vasc Biol. 1996;16:665-672.)</description><subject>Biological and medical sciences</subject><subject>Blood coagulation. Blood cells</subject><subject>Cells, Cultured</subject><subject>Chondroitin Sulfates - isolation &amp; purification</subject><subject>Chondroitin Sulfates - metabolism</subject><subject>Electrophoresis, Polyacrylamide Gel</subject><subject>Endothelium, Vascular - cytology</subject><subject>Endothelium, Vascular - metabolism</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>General aspects, investigation methods, hemostasis, fibrinolysis</subject><subject>Glycosaminoglycans - isolation &amp; purification</subject><subject>Glycosaminoglycans - metabolism</subject><subject>Heparitin Sulfate - isolation &amp; purification</subject><subject>Heparitin Sulfate - metabolism</subject><subject>Humans</subject><subject>Molecular and cellular biology</subject><subject>Proteoglycans - isolation &amp; purification</subject><subject>Proteoglycans - metabolism</subject><subject>Tissue Plasminogen Activator - metabolism</subject><subject>Umbilical Veins - cytology</subject><subject>Umbilical Veins - metabolism</subject><issn>1079-5642</issn><issn>1524-4636</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkU1vEzEQhlcIVErhzAnJQojbpv727jFELa1UiR7SXq1Zrzdx8drB3qUKd_43jhL1wGE045nHr0bzVtVHgheESHKJyWK5flwQuRALKcWr6pwIymsumXxdaqzaWkhO31bvcn7CGHNK8Vl11rSSKcrPq7-3OXqYXAwIQo9WW0hgJpvcn2MzDmjtcp5tvd7vLLr3kEcX4sYGtDST-w1TTPU3F3oXNug-xcnGjd8bCBldpziim3mEgB7GznlnwKNH6wK6Cn2ctta70lhZ7_P76s0APtsPp3xRPVxfrVc39d2P77er5V1tuFRNreTQd5RwKoAyJvpeAFbGdB0jAzSqwbgdrBDWcolpSyXuhSCmA1B9A4wYdlF9PeruUvw12zzp0WVTNoBg45x1kWBSCVrAz_-BT3FOoeymablh03LFC3R5hEyKOSc76F1yI6S9Jlgf3NGY6OKOJlILXdwpPz6dZOdutP0Lf7KjzL-c5pDLtYYEwbj8gjHccCUOMvyIPUdfvMo__fxsk95a8NNWH1xmEouatG1J5VmXwA37B7reqF4</recordid><startdate>199605</startdate><enddate>199605</enddate><creator>Bohm, Thomas</creator><creator>Geiger, Margarethe</creator><creator>Binder, Bernd R</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>199605</creationdate><title>Isolation and Characterization of Tissue-Type Plasminogen Activator-Binding Proteoglycans From Human Umbilical Vein Endothelial Cells</title><author>Bohm, Thomas ; Geiger, Margarethe ; Binder, Bernd R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4678-76fdb21425a2335dd5a07ccbb31fa878009fe55ee46029260d551cbaa7d8a31c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Biological and medical sciences</topic><topic>Blood coagulation. Blood cells</topic><topic>Cells, Cultured</topic><topic>Chondroitin Sulfates - isolation &amp; purification</topic><topic>Chondroitin Sulfates - metabolism</topic><topic>Electrophoresis, Polyacrylamide Gel</topic><topic>Endothelium, Vascular - cytology</topic><topic>Endothelium, Vascular - metabolism</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>General aspects, investigation methods, hemostasis, fibrinolysis</topic><topic>Glycosaminoglycans - isolation &amp; purification</topic><topic>Glycosaminoglycans - metabolism</topic><topic>Heparitin Sulfate - isolation &amp; purification</topic><topic>Heparitin Sulfate - metabolism</topic><topic>Humans</topic><topic>Molecular and cellular biology</topic><topic>Proteoglycans - isolation &amp; purification</topic><topic>Proteoglycans - metabolism</topic><topic>Tissue Plasminogen Activator - metabolism</topic><topic>Umbilical Veins - cytology</topic><topic>Umbilical Veins - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bohm, Thomas</creatorcontrib><creatorcontrib>Geiger, Margarethe</creatorcontrib><creatorcontrib>Binder, Bernd R</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Arteriosclerosis, thrombosis, and vascular biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bohm, Thomas</au><au>Geiger, Margarethe</au><au>Binder, Bernd R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Isolation and Characterization of Tissue-Type Plasminogen Activator-Binding Proteoglycans From Human Umbilical Vein Endothelial Cells</atitle><jtitle>Arteriosclerosis, thrombosis, and vascular biology</jtitle><addtitle>Arterioscler Thromb Vasc Biol</addtitle><date>1996-05</date><risdate>1996</risdate><volume>16</volume><issue>5</issue><spage>665</spage><epage>672</epage><pages>665-672</pages><issn>1079-5642</issn><eissn>1524-4636</eissn><coden>ATVBFA</coden><abstract>We analyzed the tissue-type plasminogen activator (TPA)-binding proteoglycans (PGs) on human umbilical vein endothelial cells (HUVECs), which were metabolically labeled with [sup 35 S]Na2 SO4. Cell extracts were then prepared and subjected to affinity chromatography on diisopropyl fluorophosphate (DFP)-inactivated TPA-Sepharose 4B. Approximately 6% of the incorporated Sulfur radioactivity bound to DFP-treated TPA-Sepharose 4B and was eluted with 2 mol/L NaCl. In addition to NaCl, heparin, arginine, and lysine but not glycine, epsilon-amino-n-caproic acid, or aspartic acid inhibited this binding and eluted the bound Sulfur radioactivity. Urea-containing polyacrylamide gel electrophoresis of the eluted material consistently revealed two main signals of Sulfur radioactivity (one with an M sub r between 600 000 and 750 000 [PGA] and the other with an Mr between 120 000 and 180 000 [PGC]). Occasionally a less intense signal with an Mr between 340 000 and 440 000 (PGB) was seen. Heparitinase treatment markedly decreased the intensities of both Sulfur signals (PGA and PGB), and chondroitinases AC and ABC abolished the Sulfur signal of PGC, indicating that most of the HUVEC-incorporated radioactivity with an affinity for TPA could be attributed to heparan sulfate- and chondroitin sulfate-like structures. Reductive elimination, which was performed to separate the possible glycosaminoglycan moieties from the core proteins, confirmed the PG-like nature of this material and again revealed heparan sulfate and chondroitin sulfate as the major glycosaminoglycan components. We therefore conclude that HUVECs synthesize TPA-binding, heparan sulfate- and chondroitin sulfate-containing PGs. In vivo, similar PGs may play a role in TPA binding to endothelial cells and thereby possibly influence TPA activity and/or provide an intravascular storage pool of TPA. (Arterioscler Thromb Vasc Biol. 1996;16:665-672.)</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>8963724</pmid><doi>10.1161/01.ATV.16.5.665</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1079-5642
ispartof Arteriosclerosis, thrombosis, and vascular biology, 1996-05, Vol.16 (5), p.665-672
issn 1079-5642
1524-4636
language eng
recordid cdi_proquest_miscellaneous_78036752
source MEDLINE; Journals@Ovid Complete; Alma/SFX Local Collection
subjects Biological and medical sciences
Blood coagulation. Blood cells
Cells, Cultured
Chondroitin Sulfates - isolation & purification
Chondroitin Sulfates - metabolism
Electrophoresis, Polyacrylamide Gel
Endothelium, Vascular - cytology
Endothelium, Vascular - metabolism
Fundamental and applied biological sciences. Psychology
General aspects, investigation methods, hemostasis, fibrinolysis
Glycosaminoglycans - isolation & purification
Glycosaminoglycans - metabolism
Heparitin Sulfate - isolation & purification
Heparitin Sulfate - metabolism
Humans
Molecular and cellular biology
Proteoglycans - isolation & purification
Proteoglycans - metabolism
Tissue Plasminogen Activator - metabolism
Umbilical Veins - cytology
Umbilical Veins - metabolism
title Isolation and Characterization of Tissue-Type Plasminogen Activator-Binding Proteoglycans From Human Umbilical Vein Endothelial Cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T05%3A59%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Isolation%20and%20Characterization%20of%20Tissue-Type%20Plasminogen%20Activator-Binding%20Proteoglycans%20From%20Human%20Umbilical%20Vein%20Endothelial%20Cells&rft.jtitle=Arteriosclerosis,%20thrombosis,%20and%20vascular%20biology&rft.au=Bohm,%20Thomas&rft.date=1996-05&rft.volume=16&rft.issue=5&rft.spage=665&rft.epage=672&rft.pages=665-672&rft.issn=1079-5642&rft.eissn=1524-4636&rft.coden=ATVBFA&rft_id=info:doi/10.1161/01.ATV.16.5.665&rft_dat=%3Cproquest_cross%3E17465554%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=204289474&rft_id=info:pmid/8963724&rfr_iscdi=true